Patents by Inventor Merit Cudkowicz

Merit Cudkowicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNAS IN NEURODEGENERATIVE DISORDERS
    Publication number: 20190276892
    Abstract: Provided herein are methods of treating a neurodegenerative disorder such as Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS) that include administering to a subject at least one inhibitory nucleic acid that decreases the level or activity of microRNA hsa-miR-155.
    Type: Application
    Filed: January 18, 2019
    Publication date: September 12, 2019
    Inventors: Howard Weiner, Oleg Butovsky, Merit Cudkowicz, James Berry
  • Micrornas in neurodegenerative disorders
    Patent number: 10184151
    Abstract: Provided herein are methods of treating a neurodegenerative disorder such as Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS) that include administering to a subject at least one inhibitory nucleic acid that decreases the level or activity of microRNA hsa-miR-155.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: January 22, 2019
    Assignees: The Brigham and Women's Hospital, Inc., The General Hospital Corporation
    Inventors: Howard Weiner, Oleg Butovsky, Merit Cudkowicz, James Berry
  • MICRORNAS IN NEURODEGENERATIVE DISORDERS
    Publication number: 20180023142
    Abstract: Provided herein are methods of treating a neurodegenerative disorder such as Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS) that include administering to a subject at least one inhibitory nucleic acid that decreases the level or activity of microRNA has-miR-155.
    Type: Application
    Filed: September 8, 2017
    Publication date: January 25, 2018
    Inventors: Howard Weiner, Oleg Butovsky, Merit Cudkowicz, James Berry
  • Biomarkers for amyotrophic lateral sclerosis and methods using the same
    Patent number: 8841077
    Abstract: The present invention provides various biomarkers of amyotrophic lateral sclerosis (ALS). The present invention also provides various methods of using the biomarkers, including methods for diagnosis of ALS, methods of determining predisposition to ALS, methods of monitoring progression/regression of ALS, methods of assessing efficacy of compositions for treating ALS, methods of screening compositions for activity in modulating biomarkers of ALS, methods of treating ALS, as well as other methods based on biomarkers of ALS.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: September 23, 2014
    Assignees: Massachusetts General Hospital, Metabolon, Inc.
    Inventors: Lisa A. Paige, Matthew W. Mitchell, Anne Evans, Don Harvan, Kay A. Lawton, Robert Brown, Merit Cudkowicz
  • Biomarkers for amyotrophic lateral sclerosis and methods using the same
    Publication number: 20070298998
    Abstract: The present invention provides various biomarkers of amyotrophic lateral sclerosis (ALS). The present invention also provides various methods of using the biomarkers, including methods for diagnosis of ALS, methods of determining predisposition to ALS, methods of monitoring progression/regression of ALS, methods of assessing efficacy of compositions for treating ALS, methods of screening compositions for activity in modulating biomarkers of ALS, methods of treating ALS, as well as other methods based on biomarkers of ALS.
    Type: Application
    Filed: February 27, 2007
    Publication date: December 27, 2007
    Applicant: Metabolon, Inc.
    Inventors: Lisa Paige, Matthew Mitchell, Anne Evans, Don Harvan, Kay Lawton, Robert Brown, Merit Cudkowicz